Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Neurology
Disease Category: Gliomas
Location: United States, GA
ACNS0822: A Randomized, Phase II/III Study of Vorinotat (IND#71976) and Local Irradiation OR Temozolomide and Local Irradiation OR Bevacizumab (IND#7921) and Local Irradiation Followed by Maintenance Bevacizumab and Temozolomide in Children with Newly Diagnosed High-Grade Gliomas
CW ID: 181732
Date Last Changed:
May 23, 2014
Patricia GreenMemorial University Medical Center4700 Waters AvenueHoskins Center - 2nd FloorSavannah, GA 31404Phone: 912-350-8707
Memorial University Medical Center
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.